MECHANISM OF RAF1 ACTIVATION
RAF1 激活机制
基本信息
- 批准号:2824638
- 负责人:
- 金额:$ 18.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-09-01 至 2003-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION: Raf-1 is a physiological kinase upstream of MEK 1/2, whose
downstream target, MAPK/Erk was first identified as an insulin-responsive
kinase. Raf-1 is a major downstream effector of the proto-oncogene c-Ras
and its activation is crucial for the regulation of proliferation,
differentiation and other cellular functions. Despite this, knowledge of
the detailed mechanism of Raf activation is still incomplete. Studies from
a number of laboratories have suggested that extracellular signals, such
as insulin, IGF and EGF initially interacting with its amino-terminal
regulatory domain. Findings by others and these investigators suggest that
this binding opens the tight structure of inactive Raf- and makes it
accessible to as yet unidentified activators, which lock Raf in an active
state by phosphorylation and possibly other mechanisms. We have recently
shown that 14-3-3 is required for this activation process, either by
mediating dimerization of Raf-1 or causing it to interact with other
protein factors that assist in the assembly of an activatable Raf
activation. The proposed studies will examine this model using biochemical
and molecular approaches. The specific aims are as follows: 1. To
elucidate the mechanism by which oligomerization/dimerization contributes
to the activation of Raf-1. 2. To explore the role of 14-3-3 in the
regulation of Raf kinase activity. 3. To identify sequences on Raf that
are critical for its activation. The focus will be on identifying a new
phospho-peptide that appear on the peptide map of Raf-1 when EGF activates
it. 4. To identify the kinase that phosphorylates the sequences described
in aim 3. These studies should provide new insights into the mechanism by
which Raf-1 is activated in responses to changes in its extracellular and
intracellular milieu. They should also expend our understanding of the
role 14-3-3 and of dimerization in cellular signal transduction.
描述:Raf-1是MEK 1/2上游的生理激酶,其
下游靶点MAPK/Erk首先被鉴定为胰岛素应答性的
激酶。Raf-1是原癌基因c-Ras的主要下游效应子
并且其活化对于增殖的调节是至关重要的,
分化和其他细胞功能。尽管如此,
Raf激活的详细机制尚不完全。研究从
一些实验室已经提出,细胞外信号,如
如胰岛素、IGF和EGF最初与其氨基末端相互作用,
监管领域。其他人和这些研究人员的发现表明,
这种结合打开了无活性Raf-的紧密结构,
可访问到尚未识别的激活器,将Raf锁定在一个活跃的
通过磷酸化和可能的其他机制来调节。我们最近
显示14-3-3是这个激活过程所需的,或者通过
介导Raf-1的二聚化或使其与其它分子相互作用,
协助可活化Raf装配的蛋白质因子
activation.拟议中的研究将使用生物化学方法来检验这一模型。
和分子方法。具体目标如下:1.到
阐明低聚/二聚作用的机制
Raf-1的激活。2.探讨14-3-3在
Raf激酶活性的调节。3.为了确定Raf上的序列,
对它的激活至关重要重点将是确定一个新的
当EGF激活时,Raf-1的肽图上出现的磷酸肽
了4.为了鉴定磷酸化所述序列的激酶,
在目标3中。这些研究应该提供新的见解的机制,
其中Raf-1响应于其细胞外的变化而被激活,
细胞内环境他们还应该扩大我们对
作用14-3-3和细胞信号转导中的二聚化。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Zhijun Luo其他文献
Zhijun Luo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Zhijun Luo', 18)}}的其他基金
AMPK regulates angiogenesis by inhibition of the ALK1 signaling pathway
AMPK 通过抑制 ALK1 信号通路调节血管生成
- 批准号:
8827357 - 财政年份:2014
- 资助金额:
$ 18.26万 - 项目类别:
The fuel sensing enzyme AMPK in the pathogenesis of prostate cancer
前列腺癌发病机制中的燃料感应酶 AMPK
- 批准号:
7665139 - 财政年份:2006
- 资助金额:
$ 18.26万 - 项目类别:
The fuel sensing enzyme AMPK in the pathogenesis of prostate cancer
前列腺癌发病机制中的燃料感应酶 AMPK
- 批准号:
7293548 - 财政年份:2006
- 资助金额:
$ 18.26万 - 项目类别:
The fuel sensing enzyme AMPK in the pathogenesis of prostate cancer
前列腺癌发病机制中的燃料感应酶 AMPK
- 批准号:
7893804 - 财政年份:2006
- 资助金额:
$ 18.26万 - 项目类别:
The fuel sensing enzyme AMPK in the pathogenesis of prostate cancer
前列腺癌发病机制中的燃料感应酶 AMPK
- 批准号:
7478378 - 财政年份:2006
- 资助金额:
$ 18.26万 - 项目类别:
The fuel sensing enzyme AMPK in the pathogenesis of prostate cancer
前列腺癌发病机制中的燃料感应酶 AMPK
- 批准号:
7148255 - 财政年份:2006
- 资助金额:
$ 18.26万 - 项目类别:
The fuel sensing enzyme AMPK in the pathogenesis of prostate cancer
前列腺癌发病机制中的燃料感应酶 AMPK
- 批准号:
7997856 - 财政年份:2006
- 资助金额:
$ 18.26万 - 项目类别:
相似海外基金
Non-canonical chimeric proteins generated during Adenovirus infection
腺病毒感染期间产生的非典型嵌合蛋白
- 批准号:
10448505 - 财政年份:2021
- 资助金额:
$ 18.26万 - 项目类别:
Non-canonical chimeric proteins generated during Adenovirus infection
腺病毒感染期间产生的非典型嵌合蛋白
- 批准号:
10312411 - 财政年份:2021
- 资助金额:
$ 18.26万 - 项目类别:
Increasing efficiency in formation of chimeric proteins
提高嵌合蛋白形成的效率
- 批准号:
561998-2021 - 财政年份:2021
- 资助金额:
$ 18.26万 - 项目类别:
University Undergraduate Student Research Awards
Decoration and Dimerization of Chimeric Proteins Mediated by Coiled-Coil Interactions
卷曲螺旋相互作用介导的嵌合蛋白的修饰和二聚化
- 批准号:
537306-2018 - 财政年份:2019
- 资助金额:
$ 18.26万 - 项目类别:
Collaborative Research and Development Grants
Exploring the therapeutic potential of chimeric proteins
探索嵌合蛋白的治疗潜力
- 批准号:
1947736 - 财政年份:2017
- 资助金额:
$ 18.26万 - 项目类别:
Studentship
TARGETING PROTEIN INTERACTIONS AND DESIGNING CHIMERIC PROTEINS
靶向蛋白质相互作用并设计嵌合蛋白质
- 批准号:
8364271 - 财政年份:2011
- 资助金额:
$ 18.26万 - 项目类别:
Therapeutic peanut allergen Fc gamma chimeric proteins to treat peanut allergy
用于治疗花生过敏的治疗性花生过敏原 Fc γ 嵌合蛋白
- 批准号:
8444422 - 财政年份:2010
- 资助金额:
$ 18.26万 - 项目类别:
Cat allergen-human Fc-gamma1 chimeric proteins to treat cat allergy
猫过敏原-人Fc-gamma1嵌合蛋白治疗猫过敏
- 批准号:
7907314 - 财政年份:2010
- 资助金额:
$ 18.26万 - 项目类别:
TARGETING PROTEIN INTERACTIONS AND DESIGNING CHIMERIC PROTEINS
靶向蛋白质相互作用并设计嵌合蛋白质
- 批准号:
8171849 - 财政年份:2010
- 资助金额:
$ 18.26万 - 项目类别:
Therapeutic peanut allergen Fc gamma chimeric proteins to treat peanut allergy
用于治疗花生过敏的治疗性花生过敏原 Fc γ 嵌合蛋白
- 批准号:
8313432 - 财政年份:2010
- 资助金额:
$ 18.26万 - 项目类别:














{{item.name}}会员




